Emerson Gears Up to Post Q3 Earnings: Here's What to Expect

Let’s see how things have shaped up for Emerson prior to the announcement.

Factors Likely to Have Shaped EMR’s Quarterly Performance

Strength across Emerson’s Intelligent Devices and Software and Systems groups is likely to have driven its performance in the fiscal third quarter. Solid momentum in the final control segment, driven by strength in power and LNG end markets, is likely to have benefited the top-line performance of its Intelligent Devices group in the fiscal third quarter. Robust growth across the Americas within the Sensors segment is also likely to aid the Intelligent Devices group’s results. For the fiscal third quarter, the Zacks Consensus Estimate for the group’s total sales is pegged at $2.64 billion, up 5.2% sequentially.

Solid momentum in the Control Systems & Software segment, supported by strength in the power and life sciences end markets, is likely to have augmented the performance of the Software & Systems group. Also, strength in the aerospace & defense and semiconductor end markets has been aiding the Test & Measurement segment. For the fiscal third quarter, the consensus estimate for the group’s total sales is pegged at $1.59 billion, indicating a 6% rise from the previous quarter’s number.

Robust growth across the Americas region is expected to have augmented the Safety & Productivity segment’s performance in the to-be-reported quarter.

The company has remained focused on expanding its product offerings and market presence through buyouts. In March 2025, Emerson acquired the remaining shares of AspenTech, making it a wholly owned subsidiary. This move strengthened the company’s automation portfolio and enhanced its software-defined control capabilities. The buyout is expected to have boosted EMR’s top line in the quarter.

However, rising costs and expenses owing to higher input costs and restructuring-related actions are likely to have affected EMR’s margin performance. Also, given the company’s substantial international operations, foreign currency headwinds are likely to have marred its margins and profitability.

Earnings Whispers

Our proven model does not conclusively predict an earnings beat for Emerson this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat, which is not the case here, as elaborated below.

Earnings ESP: EMR has an Earnings ESP of -1.21% as the Zacks Consensus Estimate is pegged at $1.68 per share, higher than the Most Accurate Estimate of $1.66. You can uncover the best stocks before they’re reported with our Earnings ESP Filter.

Zacks Rank: EMR currently carries a Zacks Rank #4 (Sell). 

You can see the complete list of today’s Zacks #1 Rank stocks here.

Stocks With the Favorable Combination

Ferguson Enterprises Inc. FERG has an Earnings ESP of +1.22% and a Zacks Rank of 2 at present. The company is slated to release second-quarter 2026 results on Aug. 10.

Ferguson’s earnings surpassed the Zacks Consensus Estimate in each of the trailing four quarters, the average surprise being 6.5%.

Xometry, Inc. XMTR has an Earnings ESP of +66.67% and a Zacks Rank of 3 at present. The company is slated to release second-quarter 2026 results on Aug. 4.

Xometry’s earnings surpassed the Zacks Consensus Estimate in three of the trailing four quarters and matched the mark in one, the average surprise being 46.1%.

Ball Corporation BALL has an Earnings ESP of +0.98% and a Zacks Rank of 3 at present. The company is slated to release second-quarter 2026 results on Aug. 4.

Ball Corp.’s earnings surpassed the Zacks Consensus Estimate in three of the trailing four quarters while matching the mark in one, the average surprise being 3.8%.

Zacks' Research Chief Names "Stock Most Likely to Double"

Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.

This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research